GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-12

Study Completion Date

2031-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Perioperative hypersensitivity reactions are still associated with significant morbidity and mortality despite early recognition and use of epinephrine. The epidemiology of these reactions evolves over time and changes with clinical practice. The main objective is to study the epidemiology of these reactions over a 10-year period, including patient phenotype, reaction phenotype and outcome of the allergic work-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Role of Hemostasis in Perioperative Anaphylaxis

NCT04825158

Hemoptysis Perioperative Complication Anaphylaxis

UNKNOWN

Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery

NCT02311309

Surgery Blood Loss

COMPLETED

Transfusion Surveillance in Anaesthesia

NCT06403163

Transfusion Reaction Transfusion Related Complication Anesthesia +5 more

RECRUITING

Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)

NCT00980616

Arthroplasty, Replacement, Hip

COMPLETED PHASE2

French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients

NCT03313583

Blood Product Transfusion for All Conditions Trauma Surgical Blood Loss +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypersensitivity, Drug

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minor and major subject
* Subject having experienced a perioperative hypersensitivity reaction between January the 1st 2017 and December the 31st 2027.
* Referred for an allegro-anesthetic workup
* Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion Criteria

* Subject having expressed opposition to participating in the study
* Inability to provide the subject with research information
* Subject under guardianship or guardianship
* Subject under safeguard of justice

Minimum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No